Filed: 5/15/2026ACC: 0001104659-26-062465
📋 What this filing means
DATA COLLECTIVE IV GP, LLC filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $55.95M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$55.95M
Total AUM (reported)
11.55M
Total Shares
Allocation by class
COM CL A$27.77M49.6%
CL A$18.24M32.6%
CL A ORD SHS$8.04M14.4%
COM SHS$1.90M3.4%
Portfolio Concentration
Top 3$54.05M96.6%
4–10$1.90M3.4%
Top 3 weight
96.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 11.55M
Sole
Full voting authority
11.55M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole4
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings4
Rows:
Evolv Technologies Holdings, Inc.
SOLEShares4.59M
TypeSH
Market value$27.77M
49.63%
Sole
4.59M
Shared
0.00
None
0.00
Recursion Pharmaceuticals, Inc.
SOLEShares5.94M
TypeSH
Market value$18.24M
32.60%
Sole
5.94M
Shared
0.00
None
0.00
Horizon Quantum Holdings Ltd
SOLEShares915.20K
TypeSH
Market value$8.04M
14.38%
Sole
915.20K
Shared
0.00
None
0.00
Definium Therapeutics, Inc. (MindMed)
SOLEShares100.35K
TypeSH
Market value$1.90M
3.39%
Sole
100.35K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Evolv Technologies Holdings, Inc.SOLE | COM CL A | 4.59M | SH | $27.77M 49.63% | 4.59M | 0.00 | 0.00 |
Recursion Pharmaceuticals, Inc.SOLE | CL A | 5.94M | SH | $18.24M 32.60% | 5.94M | 0.00 | 0.00 |
Horizon Quantum Holdings LtdSOLE | CL A ORD SHS | 915.20K | SH | $8.04M 14.38% | 915.20K | 0.00 | 0.00 |
Definium Therapeutics, Inc. (MindMed)SOLE | COM SHS | 100.35K | SH | $1.90M 3.39% | 100.35K | 0.00 | 0.00 |